BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/24/2022 2:13:21 PM | Browse: 329 | Download: 972
 |
Received |
|
2021-10-23 15:11 |
|
Peer-Review Started |
|
2021-10-23 15:12 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-12-02 08:57 |
|
Revised |
|
2021-12-16 02:35 |
|
Second Decision |
|
2022-02-14 05:28 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-02-16 07:17 |
|
Articles in Press |
|
2022-02-16 07:17 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-03-08 00:58 |
|
Publish the Manuscript Online |
|
2022-03-24 14:13 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Benign course of residual inflammation at end of treatment of liver transplant recipients after sofosbuvir based therapy
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Bahaaeldeen Ismail, Karim M Benrajab, Pablo Bejarano, Phillip Ruiz, Debbie Sears, Andreas Tzakis and Xaralambos Bobby Zervos |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Karim M Benrajab, MD, Assistant Professor, Internal Medicine/ Division of Digestive Diseases and Nutrition, University of Kentucky College of Medicine, 770 Rose Street, MN649, Lexington, KY 40536, United States. karimbenrajab@gmail.com |
| Key Words |
Immunosuppression; Liver transplantation; Recurrent hepatitis C; Sustained virologic response; Interferon |
| Core Tip |
Unexplained residual inflammation can be seen in a subset of liver transplant recipients successfully treated with direct-acting antiviral therapies; however, it does not seem to affect graft function. An extensive clinical and histopathologic workup should still be performed to exclude other potentially treatable conditions. |
| Publish Date |
2022-03-24 14:13 |
| Citation |
Ismail B, Benrajab KM, Bejarano P, Ruiz P, Sears D, Tzakis A, Zervos XB. Benign course of residual inflammation at end of treatment of liver transplant recipients after sofosbuvir based therapy. World J Hepatol 2022; 14(3): 602-611 |
| URL |
https://www.wjgnet.com/1948-5182/full/v14/i3/602.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v14.i3.602 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
